These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 16389946)

  • 1. Angiogenesis in gliomas: imaging and experimental therapeutics.
    Gagner JP; Law M; Fischer I; Newcomb EW; Zagzag D
    Brain Pathol; 2005 Oct; 15(4):342-63. PubMed ID: 16389946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
    Kepes JJ
    Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiangiogenic therapy in malignant glioma: promise and challenge.
    Sathornsumetee S; Rich JN
    Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis and antiangiogenic therapy for malignant gliomas.
    Takano S; Kamiyama H; Tsuboi K; Matsumura A
    Brain Tumor Pathol; 2004; 21(2):69-73. PubMed ID: 15700836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
    Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
    Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenesis: biology and utility in the treatment of gliomas.
    Chamberlain MC
    Expert Rev Neurother; 2008 Oct; 8(10):1419-23. PubMed ID: 18928336
    [No Abstract]   [Full Text] [Related]  

  • 8. Colon perforation during antiangiogenic therapy for malignant glioma.
    Norden AD; Drappatz J; Ciampa AS; Doherty L; LaFrankie DC; Kesari S; Wen PY
    Neuro Oncol; 2009 Feb; 11(1):92-5. PubMed ID: 18757774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro- and Antiangiogenic Factors in Gliomas: Implications for Novel Therapeutic Possibilities.
    Groblewska M; Mroczko B
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in gliomas: biology and molecular pathophysiology.
    Fischer I; Gagner JP; Law M; Newcomb EW; Zagzag D
    Brain Pathol; 2005 Oct; 15(4):297-310. PubMed ID: 16389942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
    Argyriou AA; Giannopoulou E; Kalofonos HP
    Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor inhibitors in malignant gliomas.
    Brastianos PK; Batchelor TT
    Target Oncol; 2010 Sep; 5(3):167-74. PubMed ID: 20821351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
    Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
    Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of glioma-associated neovascularization.
    Hardee ME; Zagzag D
    Am J Pathol; 2012 Oct; 181(4):1126-41. PubMed ID: 22858156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
    Valable S; Petit E; Roussel S; Marteau L; Toutain J; Divoux D; Sobrio F; Delamare J; Barré L; Bernaudin M
    Nucl Med Biol; 2011 Aug; 38(6):781-93. PubMed ID: 21843775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-angiogenesis treatment for brain tumors: present and future].
    Takano S; Matsumura A
    No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiobiology and vascular targeting in glioma.
    Short SC; Harney J
    Curr Opin Neurol; 2003 Dec; 16(6):651-5. PubMed ID: 14624072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.
    Samuel DP; Wen PY; Kieran MW
    Expert Opin Investig Drugs; 2009 Jul; 18(7):973-83. PubMed ID: 19548852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.
    Rege TA; Fears CY; Gladson CL
    Neuro Oncol; 2005 Apr; 7(2):106-21. PubMed ID: 15831230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors.
    Puduvalli VK; Sawaya R
    J Neurooncol; 2000; 50(1-2):189-200. PubMed ID: 11245279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.